SkinHealth Systems Inc.

For the period ended Jun 30, 2026. Filed Aug 6, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 6, 2026

SKIN$16.77+6.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets (Unaudited)

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except for share amounts)

	June 30, 2026	December 31, 2025
ASSETS
Current assets:
Cash, cash equivalents, and restricted cash	$206,074	$232,673
Accounts receivable, net of allowances for estimated credit losses of $3,652 and $6,022 at June 30, 2026 and December 31, 2025, respectively	17,640	21,741
Inventories	46,842	48,012
Income tax receivable	1,992	1,696
Prepaid expenses and other current assets	22,693	5,395
Total current assets	295,241	309,517
Property and equipment, net	2,088	2,538
Right-of-use assets, net	19,397	11,570
Intangible assets, net	30,218	35,763
Goodwill	126,349	126,621
Deferred income tax assets, net	2,350	1,925
Other assets	10,930	11,869
TOTAL ASSETS	$486,573	$499,803
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of convertible senior notes, net	$103,089	$123,959
Accounts payable	16,051	15,631
Accrued payroll-related expenses	13,114	24,947
Lease liabilities, current	3,857	5,128
Income tax payable	482	1,226
Other accrued expenses	31,605	15,384
Total current liabilities	168,198	186,275
Lease liabilities, non-current	17,975	9,238
Deferred income tax liabilities, net	393	393
Convertible senior notes, net	242,120	240,431
Other long-term liabilities	2,319	2,410
Total liabilities	431,005	438,747
Commitments and Contingencies (Note 6)
Stockholders’ equity:
Class A Common Stock, $0.0001 par value; 320,000,000 shares authorized; 130,104,671 and 127,520,823 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively	13	13
Additional paid-in capital	583,737	579,961
Accumulated other comprehensive loss	(1,399)	(1,434)
Accumulated deficit	(526,783)	(517,484)
Total stockholders’ equity	55,568	61,056
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$486,573	$499,803

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.